The study looked at vaccines deployed during outbreaks of five deadly diseases.

The life-saving impact of global vaccine stockpiles to address outbreaks of vaccine-preventable diseases has been ...

In September an Ebola vaccine developed by the U.S. National Institute for Health will be tested in humans for the first time in its first phase 1 clinical trial.

Emergency vaccination campaigns have slashed deaths from major infectious disease outbreaks by nearly 60 per cent since 2000, ...

A new study shows that in addition to preventing infections, the Ebola vaccine can save some people who are already sick with the often fatal disease.

Ervebo, an Ebola vaccine, is neither experimental, nor contains the Ebola virus. A different virus used in the vaccine, vesicular stomatitis, can shed. Denver health care workers who received the ...

Ebola is one of the most feared infectious diseases, with more than half of those infected dying. A vaccine has now been shown to cut that mortality rate in half.

The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea.

Press Release - Researchers at Burnet Institute, in collaboration with Gavi, the Vaccine Alliance, have provided the world's first ever look at the historical impact of emergency vaccination efforts ...

A shipment of Ebola vaccine candidates set to be used in a clinical trial have arrived in Uganda, where an outbreak has infected 142 people and killed at least 56, health authorities said on Thursday.

The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea.